Metabolic Complications of HIV and Antiretroviral Therapy: Dyslipidemia, Insulin Resistance, and Cardiovascular Disease

  • Authors: Judith S. Currier, MD, MSc; Risa Hoffman, MD, MPH (More Info)
  • Editors in Chief: Joseph J. Eron, Jr., MD; Daniel R. Kuritzkes, MD
  • Last Reviewed: 10/10/18 (What's New)

Summary

  • Prevalence of dyslipidemia in resource-limited settings is not well characterized
  • Emerging data suggest that dyslipidemia and other metabolic toxicities are associated with HIV and ART in many developing countries[George 2009; Mutimura 2007; Manuthu 2008; Hiransuthikul 2007; Muyanja 2016; Nguyen 2016]
  • Extreme poverty limits the ability of individuals to make choices about dietary intake and hinders healthy lifestyle patterns

Action required